RIL
CPRX

Rothschild Investment LLC’s Catalyst Pharmaceutical CPRX Stock Holding History

Rothschild Investment LLC’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$49.6K Buy
2,003
+59
+3% +$1.41K ﹤0.01% 1121
2025
Q4 		$45.4K Buy
1,944
+284
+17% +$6.33K ﹤0.01% 1057
2025
Q3 		$32.7K Buy
1,660
+1,520
+1,086% +$31.3K ﹤0.01% 1114
2025
Q2 		$3.04K Sell
140
-40
-22% -$944 ﹤0.01% 1778
2025
Q1 		$4.37K Buy
180
+60
+50% +$1.35K ﹤0.01% 1506
2024
Q4 		$2.5K Buy
120
+30
+33% +$644 ﹤0.01% 1665
2024
Q3 		$1.79K Buy
90
+50
+125% +$927 ﹤0.01% 1789
2024
Q2 		$620 Buy
40
+30
+300% +$467 ﹤0.01% 1885
2024
Q1 		$159 Buy
+10
New +$151 ﹤0.01% 1866

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Rothschild Investment LLC's CPRX Position: Q1 2026 in Review

Rothschild Investment LLC increased its Catalyst Pharmaceutical (CPRX) stake by 3% in Q1 2026, buying an estimated $1.41K and bringing the position to 2,003 shares worth $49.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1121.

Rothschild Investment LLC first reported a position in CPRX in Q1 2024 and has held it in 9 quarters since. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.

  • Rothschild Investment LLC held 2,003 shares of Catalyst Pharmaceutical worth $49.6K as of Q1 2026.
  • Rothschild Investment LLC bought 59 Catalyst Pharmaceutical shares in Q1 2026, an estimated $1.41K.
  • Catalyst Pharmaceutical made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q1 2026, its #1121 holding.
  • Rothschild Investment LLC first reported a position in Catalyst Pharmaceutical in Q1 2024 and has held it in 9 quarters since.
  • 380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.

Based on Rothschild Investment LLC's 13F filing for Q1 2026, filed 7 May 2026.